Autoinflammatory & Behçet
IL-1-driven systemic inflammatory conditions including CAPS, FMF, and Behçet’s Disease. Appleglc.com sources Ilaris, Arcalyst, Kineret, Olumiant, Otezla, and Humira with global FDA-approved access.
Ilaris
Canakinumab
Arcalyst
Rilonacept
Kineret
Anakinra
Olumiant
Baricitinib
Rilonacept
Rilonacept
Otezla
Apremilast
Humira
Adalimumab
Yutiq
Fluocinolone Acetonide
Colcrys
Colchicine
Imuran
Azathioprine
Prednisone
Prednisone
Solu-Medrol
Methylprednisolone Sodium Succinate
Remicade
Infliximab
Enbrel
Etanercept
Cimzia
Certolizumab Pegol
Simponi
Golimumab
Methotrexate
Methotrexate
Plaquenil
Hydroxychloroquine
Cellcept
Mycophenolate Mofetil
Cytoxan
Cyclophosphamide
Xeljanz
Tofacitinib
Rinvoq
Upadacitinib
Actemra
Tocilizumab